Despite efforts to develop new antibiotics, antibacterial resistance still develops too fast for
drug discovery to keep pace. Often, resistance against a new drug develops even before it …

Shorter (6–9 months), fully oral regimens containing new and repurposed drugs are now the
first-choice option for the treatment of drug-resistant tuberculosis (DR-TB). Clofazimine, long …

The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
and the associated disease COVID-19, requires therapeutic interventions that can be rapidly …

In their 60-year history, dapsone and the sulfones have been used as both antibacterial and
anti-inflammatory agents. Dapsone has been used successfully to treat a range of …

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th
Edition, helps you safely and effectively treat the skin disorders you're likely to see in your …

Pyoderma gangrenosum (PG) is a rare noninfectious neutrophilic dermatosis. Clinically it
starts with sterile pustules that rapidly progress and turn into painful ulcers of variable depth …

In the first part of the review, topical agents and first-line systemic treatment options for
cutaneous lupus erythematosus were discussed whereas in the second part, recent …

Background: Open Access Editor's Choice Review Pyrazine and Phenazine Heterocycles:
Platforms for Total Synthesis and Drug Discovery by Robert W. Huigens III*, Beau R …

Background Clofazimine is an antimicrobial agent that has activity in vitro against
mycobacteria. Increasingly, it has been used for the treatment of nontuberculous …

Among different strategies to develop novel therapies, drug repositioning (aka repurposing)
aims at identifying new uses of an already approved or investigational drug. This approach …